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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMResults: Analysis of coverage revealed an important impact of baseline strut-wall ISA
distance on the risk of incomplete strut coverage at follow-up. Malapposed segments
with an ISA detachment < 100 mm at baseline showed complete strut coverage at
follow-up whereas segments with a maximal ISA detachment distance of 100-300 mm
and >300 mm had 6.1 % and 15.7% of their struts still uncovered at follow-up
respectively (p < 0.001).
Conclusions: Flow disturbances and risk of delayed strut coverage both increase with
ISA detachment distance. Insights from this study are important for understanding
malapposition as a quantitative, rather than binary phenomenon (present or absent),
and to deﬁne the threshold of ISA detachment that might beneﬁt from optimization
during stent implantation.
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Background: Rupture of atherosclerotic plaque and resulting thrombosis is the basis
for acute coronary syndrome (ACS). Standard arteriography is commonly used to
guide percutaneous treatment of ACS but it has limited ability to detect thrombus or
plaque rupture site. Intravascular ultrasound (IVUS) has improved capabilities to
detect these lesions. However, optical coherence tomography (OCT) is more sensitive
than IVUS in detecting thrombus and plaque rupture site which can potentially
improve stent positioning.
Methods: Retrospective review of OCT images in 46 patients who presented with
ST-elevation myocardial infarction (STEMI) and non-ST elevation myocardial
infarction (NSTEMI) was performed. The plaque rupture site and thrombus were
identiﬁed and the distance from the two were measured.
Results: Plaque rupture site was identiﬁed in 80% of cases. Thrombus was identiﬁed
in 89% of STEMI cases and 67% of NSTEMI cases (n¼0.09). One patient had the
thrombus upstream, one patient had it at the rupture site, and the remaining 44 patients
had it downstream to the plaque rupture site. Mean distance between the thrombus and
plaque rupture site is shown in graph.Conclusions: OCT has good sensitivity in identifying plaque rupture site and
thrombus in patients with STEMI and NSTEMI. The mean distance between the
plaque rupture site and the thrombus was 5.1 mm suggesting that using standard
arteriography to guide stenting may lead to suboptimal treatment since the stent can
cover the thrombotic site but miss the plaque rupture site that remains thrombogenic.
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Background: The beneﬁts of the ﬁrst available “dual” therapy approach endothelial-
progenitor-cell capturing sirolimus-eluting stent (COMBO Stent, OrbusNeich Medi-
cal, FL, USA) were studied.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/ImMethods: Using 4 longitudinal sequential OCTs in this prospective, single center
study, 61 patients treated by COMBO Stent had baseline OCT (for optimal stent
apposition), at early FUs (4 monthly groups in 1:2:2:1 ratio from 2nd to 5th month for
healing proﬁle [% strut coverage] using 6 Categories), at 9M (for neointima), and a
ﬁnal 24M OCT (for late loss outcomes). Clinical event adjudication, angiographic and
OCT analyses were performed by CRF core laboratory.
Results: 61 patients (33% DM) with 74 lesions received 88 COMBO stents. Early
strut coverage (OCT Cat. D to F) increased from 77, 86.9, 90.7, to 92.5%; interpolated
100% coverage at 150 days. 9M OCT FU Rate was 100% & TLR at 1.64%. 24M OCT
FU Rate was 68.3%; at 38M (Clinical FU Rate 98.3%) MACE Rate was 3.28%. From
9 to 24 months, neointima regression by OCT was observed:- (Mixed Model, Median,
IQR) neointimal thickness (mm) 0.14 [0.08, 0.21] vs 0.12 [0.07, 0.19], p< 0.001;
neointimal volume (mm3) 29.91 [22.13-43.22] vs 26.17 [19.94-35.81], p¼0.003;
& in-stent % plaque volume (%) 17.76 [12.21-21.22] vs 15.65 [11.17-19.35],
p¼0.011. No neoatherosclerosis or ARC deﬁnite or probable LST recorded.
Conclusions: This OCT Study demonstrates the beneﬁts of the “dual” therapy DES
approach, with excellent pro-healing proﬁle established translating into durable out-
comes of neointimal suppression (even 24M regression, for the ﬁrst time in a DES)
without late stent failure.TCT-368
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Background: After implantation of an everolimus-eluting poly-l-lactic-acid scaffold
(Absorb BVS, Abbott Vascular, Santa Clara, CA), the strut is progressively hy-
drolyzed and integrated into the arterial wall. The quantitative light intensity anal-
ysis of the strut core on Optical Coherence Tomography (OCT) enables us to assess
the light reﬂectivity of the resorbing polymer and its vessel wall integration. The aim
of this study was to compare this quantitative method with histology in porcine
model.
Methods: Seventy-six BVS were implanted in 51 pigs that underwent OCT and were
then euthanized at 3, 6, 12, 18, 24, 30 and 36 months after implantation. On OCT, the
median light intensity value of strut was calculated by dedicated software, which was
normalized by the intensity value of inter-strut neointima. On histology, integration
grade of the corresponding struts was classiﬁed into 5 groups according to the con-
nective tissue composition.
Results: A total of 275 struts were analyzed. The normalized light intensity value
(NLIV) increased steadily over time except between 12 and 18 months. (0.15 [0.12-
0.20] at 6M, 0.19 [0.15-0.25] at 12M, 0.20 [0.15-0.25] at 18M, 0.23 [0.18-0.32] at
24M, 0.32 [0.24-0.44] at 30M, and 0.52 [0.35-0.76] at 36M). As the integration grade
progresses in histology, NLIV increased gradually (Figure).
Conclusions: The OCT NLIV might be valuable for monitoring the integration
process of polymeric bioresorbable scaffolds. Histological and imaging analysis at
42 and 48 months are ongoing. The full results will be shown at the time of the
meeting.aging Intravascular - OCT B107
